Modern, new pharmacotherapy for obesity. A gastrointestinal approach.
Van Gaal
L
L
Department of Diabetology, Metabolism and Clinical Nutrition, University Hospital Antwerp, Wilrjikstraat 10 Edegem, 2650 Antwerp, Belgium. luc.van.gaal@uza.be
Mertens
I
I
Ballaux
D
D
Verkade
H J
HJ
D000681:Amylases / Q000037:antagonists & inhibitors; D000728:Androgens / Q000494:pharmacology / Q000627:therapeutic use; D019440:Anti-Obesity Agents / Q000494:pharmacology / Q000627:therapeutic use; D002951:Citrates / Q000494:pharmacology / Q000627:therapeutic use; D003503:Cyclobutanes / Q000494:pharmacology / Q000627:therapeutic use; D004041:Dietary Fats / Q000378:metabolism; D019358:Fat Substitutes / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology / Q000627:therapeutic use; D052216:Glucagon-Like Peptide 1; D005959:Glucosidases / Q000037:antagonists & inhibitors; D019382:Human Growth Hormone / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption / Q000502:physiology; D007783:Lactones / Q000494:pharmacology / Q000627:therapeutic use; D008049:Lipase / Q000037:antagonists & inhibitors; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D010446:Peptide Fragments / Q000494:pharmacology / Q000627:therapeutic use; D011498:Protein Precursors / Q000494:pharmacology / Q000627:therapeutic use; D013395:Sucrose / Q000031:analogs & derivatives* / Q000494:pharmacology
D000728:Androgens; D019440:Anti-Obesity Agents; D002951:Citrates; D003503:Cyclobutanes; D004041:Dietary Fats; D019358:Fat Substitutes; D005227:Fatty Acids; D007783:Lactones; D010446:Peptide Fragments; D011498:Protein Precursors; D019382:Human Growth Hormone; D013395:Sucrose; C013692:sucrose polyester; D052216:Glucagon-Like Peptide 1; C007999:hydroxycitric acid; D005934:Glucagon; D000077403:Orlistat; D008049:Lipase; D000681:Amylases; D005959:Glucosidases; C058254:sibutramine